secwatch.observer — SEC 8-K summary
======================================

Issuer:     Polomar Health Services, Inc. (PMHS)
CIK:        0001265521
Form:       8-K
Filed at:   2024-07-05T23:59:59+00:00
Accession:  0001493152-24-026348
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trustfeed Corp. licenses patent-pending IP from affiliate Pinata Holdings for drug delivery products
--------------------------------------------------------------------------------

- Royalty rates: 10% for metformin, 15% for sumatriptan/sildenafil, 20% for semaglutide/liraglutide on net sales.
- License is worldwide, non-exclusive, perpetual; termination for material breach or 180 days notice.
- Intended use is in products after planned acquisition of Polomar Specialty Pharmacy, announced June 28, 2024.
- Pinata Holdings is an affiliate of CWR 1, LLC, the company's majority shareholder (related party transaction).
- License covers patent-pending IP and know-how for delivery of five active ingredients (metformin, sumatriptan, semaglutide, liraglutide, sildenafil).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/0001493152-24-026348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-026348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer